445 related articles for article (PubMed ID: 26329443)
41. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
[TBL] [Abstract][Full Text] [Related]
42. Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.
Walters AS; Frauscher B; Allen R; Benes H; Chaudhuri KR; Garcia-Borreguero D; Lee HB; Picchietti DL; Trenkwalder C; Martinez-Martin P; Stebbins GT; Schrag A;
J Clin Sleep Med; 2014 Dec; 10(12):1351-7. PubMed ID: 25348243
[TBL] [Abstract][Full Text] [Related]
43. Quantitative sensory test for primary restless legs syndrome/Willis-Ekbom disease using the current perception threshold test.
Cho YW; Kang MS; Kim KT; Do SY; Lim JG; Lee SY; Motamedi GK
Sleep Med; 2017 Feb; 30():19-23. PubMed ID: 28215248
[TBL] [Abstract][Full Text] [Related]
44. The effects of periodic limb movements in sleep (PLMS) on cardiovascular disease.
Cuellar NG
Heart Lung; 2013; 42(5):353-60. PubMed ID: 23998383
[TBL] [Abstract][Full Text] [Related]
45. The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A
de Almeida CMO; Brito MMC; Bosaipo NB; Pimentel AV; Sobreira-Neto MA; Tumas V; Zuardi AW; Crippa JAS; Hallak JEC; Eckeli AL
Cannabis Cannabinoid Res; 2023 Apr; 8(2):374-378. PubMed ID: 35749710
[No Abstract] [Full Text] [Related]
46. Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients?
Portaluppi F; Cortelli P; Buonaura GC; Smolensky MH; Fabbian F
Chronobiol Int; 2009 Aug; 26(6):1206-21. PubMed ID: 19731113
[TBL] [Abstract][Full Text] [Related]
47. "Emplotted Narratives" and Structured "Behavioral Observations" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.
Ipsiroglu OS; Beyzaei N; Berger M; Wagner AL; Dhalla S; Garden J; Stockler S
CNS Neurosci Ther; 2016 Nov; 22(11):894-905. PubMed ID: 27292821
[TBL] [Abstract][Full Text] [Related]
48. F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease.
Congiu P; Fantini ML; Milioli G; Tacconi P; Figorilli M; Gioi G; Pereira B; Marrosu F; Parrino L; Puligheddu M
J Clin Sleep Med; 2017 Mar; 13(3):369-375. PubMed ID: 28095964
[TBL] [Abstract][Full Text] [Related]
49. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy.
Neyal A; Senel GB; Aslan R; Nalbantoglu M; Acikgoz S; Yilmaz N; Tumay FB; Neyal M; Karadeniz D
Sleep Med; 2015 Sep; 16(9):1036-40. PubMed ID: 26298776
[TBL] [Abstract][Full Text] [Related]
50. Nonpharmacologic Management of Restless Legs Syndrome (Willis-Ekbom Disease): Myths or Science.
Sharon D
Sleep Med Clin; 2015 Sep; 10(3):263-78, xiii. PubMed ID: 26329436
[TBL] [Abstract][Full Text] [Related]
51. Update in pediatric sleep medicine.
Owens JA
Curr Opin Pulm Med; 2011 Nov; 17(6):425-30. PubMed ID: 21921795
[TBL] [Abstract][Full Text] [Related]
52. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
[TBL] [Abstract][Full Text] [Related]
53. An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment.
Garcia-Borreguero D; Williams AM
Curr Opin Neurol; 2014 Aug; 27(4):493-501. PubMed ID: 24978636
[TBL] [Abstract][Full Text] [Related]
54. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
[TBL] [Abstract][Full Text] [Related]
55. Restless Leg Syndrome Across the Globe: Epidemiology of the Restless Legs Syndrome/Willis-Ekbom Disease.
Koo BB
Sleep Med Clin; 2015 Sep; 10(3):189-205, xi. PubMed ID: 26329429
[TBL] [Abstract][Full Text] [Related]
56. Restless legs syndrome and periodic limb movement disorder.
Rama AN; Kushida CA
Med Clin North Am; 2004 May; 88(3):653-67, viii. PubMed ID: 15087209
[No Abstract] [Full Text] [Related]
57. Management of Restless Legs Syndrome/Willis-Ekbom Disease in Hospitalized and Perioperative Patients.
Goldstein C
Sleep Med Clin; 2015 Sep; 10(3):303-10, xiv. PubMed ID: 26329440
[TBL] [Abstract][Full Text] [Related]
58. A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease).
Klingelhoefer L; Cova I; Gupta S; Chaudhuri KR
Clin Med (Lond); 2014 Oct; 14(5):520-4. PubMed ID: 25301914
[TBL] [Abstract][Full Text] [Related]
59. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
[TBL] [Abstract][Full Text] [Related]
60. Executive and Visuospatial Dysfunction in Patients With Primary Restless Legs Syndrome/Willis-Ekbom Disease: Study of a Chinese Population.
Li G; Tang H; Chen J; Qi X; Chen S; Ma J
J Clin Sleep Med; 2018 May; 14(5):785-790. PubMed ID: 29734979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
